Jiangsu Aidea Pharmaceutical Co Ltd Cash Flow Reinvestment Rate
Jiangsu Aidea Pharmaceutical Co Ltd cash flow reinvestment rate. Jiangsu Aidea Pharmaceutical Co Ltd (688488) has a Cash Flow Reinvestment Rate of 0.51x as of September 2025, reinvesting CN¥1.81 Million (capex CN¥1.81 Million ) from operating cash flow of CN¥3.56 Million. See Jiangsu Aidea Pharmaceutical Co Ltd financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Jiangsu Aidea Pharmaceutical Co Ltd (2016–2025)
Cash flow reinvestment rate of Jiangsu Aidea Pharmaceutical Co Ltd from 2016 to 2025. Historical reinvestment intensity for Jiangsu Aidea Pharmaceutical Co Ltd across 4 annual periods. Explore Jiangsu Aidea Pharmaceutical Co Ltd (688488) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Jiangsu Aidea Pharmaceutical Co Ltd Cash Flow Reinvestment Rate by Year (2016–2025)
Jiangsu Aidea Pharmaceutical Co Ltd cash flow reinvestment rate by year from 2016 to 2025. Year-by-year capital reinvestment analysis for Jiangsu Aidea Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see Jiangsu Aidea Pharmaceutical Co Ltd operating cash flow efficiency.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 2.93x | CN¥51.67 Million | CN¥17.63 Million | CN¥47.93 Million | ▼ -71.5% |
| 2020 | 10.28x | CN¥577.43 Million | CN¥56.17 Million | CN¥42.43 Million | ▲ +1439.1% |
| 2019 | 0.67x | CN¥37.54 Million | CN¥56.20 Million | CN¥33.50 Million | ▼ -70.6% |
| 2016 | 2.27x | CN¥71.01 Million | CN¥31.29 Million | CN¥71.01 Million | — |